European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing: developed by the Working Group for Cardiac Pacing Quality Indicators in collaboration with the European Heart Rhythm Association of the European Society of Cardiology.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
04 01 2022
Historique:
received: 23 05 2021
accepted: 11 07 2021
pubmed: 30 8 2021
medline: 31 3 2022
entrez: 29 8 2021
Statut: ppublish

Résumé

To develop a suite of quality indicators (QIs) for the evaluation of the care and outcomes for adults undergoing cardiac pacing. Under the auspice of the Clinical Practice Guideline Quality Indicator Committee of the European Society of Cardiology (ESC), the Working Group for cardiac pacing QIs was formed. The Group comprised Task Force members of the 2021 ESC Clinical Practice Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy, members of the European Heart Rhythm Association, international cardiac device experts, and patient representatives. We followed the ESC methodology for QI development, which involved (i) the identification of the key domains of care by constructing a conceptual framework of the management of patients receiving cardiac pacing, (ii) the development of candidate QIs by conducting a systematic review of the literature, (iii) the selection of the final set of QIs using a modified-Delphi method, and (iv) the evaluation of the feasibility of the developed QIs. Four domains of care were identified: (i) structural framework, (ii) patient assessment, (iii) pacing strategy, and (iv) clinical outcomes. In total, seven main and four secondary QIs were selected across these domains and were embedded within the 2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization therapy. By way of a standardized process, 11 QIs for cardiac pacing were developed. These indicators may be used to quantify adherence to guideline-recommended clinical practice and have the potential to improve the care and outcomes of patients receiving cardiac pacemakers.

Identifiants

pubmed: 34455442
pii: 6358481
doi: 10.1093/europace/euab193
pmc: PMC8742626
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

165-172

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Eur Heart J Qual Care Clin Outcomes. 2022 Jan 5;8(1):4-13
pubmed: 32845314
Eur Heart J. 2019 Sep 1;40(33):2745-2749
pubmed: 31505603
Circulation. 2019 Aug 20;140(8):e382-e482
pubmed: 30586772
Europace. 2021 Jul 18;23(7):983-1008
pubmed: 33878762
Eur Heart J Acute Cardiovasc Care. 2021 Apr 8;10(2):224-233
pubmed: 33550362
Eur Heart J. 2013 Jul;34(25):1869-74
pubmed: 23391583
Europace. 2021 Apr 6;23(4):494-495
pubmed: 32860039
Eur Heart J. 2019 Jun 14;40(23):1862-1869
pubmed: 31155647
J Patient Rep Outcomes. 2020 Jan 23;4(1):7
pubmed: 31974688
Eur Heart J. 2020 Jan 1;41(1):12-85
pubmed: 31820000
Int J Cardiol. 2013 Oct 3;168(3):2159-63
pubmed: 23453871
Europace. 2013 Aug;15(8):1070-118
pubmed: 23801827
N Engl J Med. 2007 Oct 11;357(15):1515-23
pubmed: 17928599
Eur Heart J. 2014 May;35(18):1186-94
pubmed: 24347317
Open Heart. 2014 Dec 10;1(1):e000177
pubmed: 25512875
BMJ Open. 2018 Apr 12;8(4):e019039
pubmed: 29654008
N Engl J Med. 2013 Apr 25;368(17):1585-93
pubmed: 23614585
Europace. 2022 Jan 4;24(1):71-164
pubmed: 34455427
Heart Rhythm. 2014 Aug;11(8):e9-51
pubmed: 24814989
Eur Heart J. 2017 Apr 1;38(13):974-982
pubmed: 28329279
Circulation. 2007 Sep 18;116(12):1349-55
pubmed: 17724263
Clin Res Cardiol. 2022 Nov;111(11):1198-1209
pubmed: 34410461
Europace. 2017 Aug 01;19(suppl_2):ii1-ii90
pubmed: 28903470
Europace. 2015 May;17(5):767-77
pubmed: 25926473
Europace. 2015 May;17(5):787-93
pubmed: 25733549
Europace. 2020 Apr 1;22(4):515-549
pubmed: 31702000

Auteurs

Suleman Aktaa (S)

Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, UK.
Leeds Institute for Data Analytics and Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Amr Abdin (A)

Internal Medicine Clinic III, Cardiology, Angiology and Intensive Care Medicine, Saarland University Hospital, Homburg/Saar, Germany.

Elena Arbelo (E)

Arrhythmia Section, Cardiology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Institut d'Investigacións Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Haran Burri (H)

Cardiology Department, Geneva University Hospital, Geneva, Switzerland.

Kevin Vernooy (K)

Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center (MUMC), Maastricht, the Netherlands.

Carina Blomström-Lundqvist (C)

Department of Medical Science and Cardiology, Uppsala University, Uppsala, Sweden.

Giuseppe Boriani (G)

Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy.

Pascal Defaye (P)

Department of Cardiology, Arrhythmias Unit, University Hospital Grenoble Alps and Grenoble Alps University, Grenoble, France.

Jean-Claude Deharo (JC)

Aix Marseille Univ, INSERM, INRAE, C2VN, Marseille, France.
Service de Cardiologie, Hôpital de la Timone, APHM, Marseille, France.

Inga Drossart (I)

Drossart (Belguim), ESC Patient Forum, Sophia Antipolis.

Dan Foldager (D)

Foldager(Denmark), ESC Patient Forum, Sophia Antipolis, France.

Michael R Gold (MR)

Division of Cardiology, Medical University of South Carolina, Charleston, SC, USA.

Jens Brock Johansen (JB)

Department of Cardiology, Odense University Hospital, Odense, Denmark.

Francisco Leyva (F)

Department of Cardiology, Aston Medical School, Aston University, Birmingham, UK.
Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK.

Cecilia Linde (C)

Department of Medicine, Karolinska Institute, Solna, Sweden.
Department of Cardiology, Karolinska University Hospital, Solna, Sweden.

Yoav Michowitz (Y)

Cardiology Department, Shaare Zedek Hospital, Affiliated to the Faculty of Medicine, Hebrew University, Jerusalem, Israel.

Mads Brix Kronborg (MB)

Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

David Slotwiner (D)

Cardiology Division, Weill Cornell Medical College, New York, NY, USA.

Torkel Steen (T)

Centre for Pacemakers and ICDs, Oslo University Hospital Ullevaal, Oslo, Norway.

José Maria Tolosana (JM)

Arrhythmia Section, Cardiology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Institut d'Investigacións Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Stylianos Tzeis (S)

Cardiology Department, Mitera General Hospital, Hygeia Group, Athens, Greece.

Niraj Varma (N)

Cleveland Clinic, Cleveland, OH, USA.

Michael Glikson (M)

Cardiology Department, Shaare Zedek Hospital, Affiliated to the Faculty of Medicine, Hebrew University, Jerusalem, Israel.

Jens Cosedis Nielsen (JC)

Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Chris P Gale (CP)

Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, UK.
Leeds Institute for Data Analytics and Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH